Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Hepatocellular × Cetuximab × 30 days × Clear all

Sponsor

Conditions

Colorectal Neoplasms 24 Squamous Cell Carcinoma of Head and Neck 19 Carcinoma, Non-Small-Cell Lung 10 Colonic Neoplasms 9 Lung Neoplasms 7 Rectal Neoplasms 5 Pancreatic Neoplasms 5 Neoplasm Metastasis 5 Carcinoma 5 Neoplasms 4 Mouth Neoplasms 4 Laryngeal Neoplasms 4 Hypopharyngeal Neoplasms 4 Head and Neck Neoplasms 4 Oropharyngeal Neoplasms 3 Carcinoma, Pancreatic Ductal 3 Solid Tumors 2 Parkinson Disease 4, Autosomal Dominant Lewy Body 2 Gastrointestinal Neoplasms 2 Tongue Neoplasms 1 Sarcoma 1 Salivary Gland Neoplasms 1 Rhabdomyosarcoma 1 Ovarian Neoplasms 1 Neoplasms, Squamous Cell 1 Neoplasms by Site 1 Nasopharyngeal Carcinoma 1 Metastatic Solid Tumors 1 Lymphoid Interstitial Pneumonia 1 Locally Recurrent Skin Squamous Cell Carcinoma 1

Interventions

Bevacizumab 13 atezolizumab 12 Specimen Handling 9 Nivolumab 8 durvalumab 6 pembrolizumab 4 X-Rays 4 Radiosurgery 4 Magnetic Resonance Spectroscopy 4 Ipilimumab 4 lenvatinib 3 Sorafenib 3 Immunoglobulin G 3 E-7386 3 Cyclophosphamide 3 Blood Specimen Collection 3 sintilimab 2 regorafenib 2 cabozantinib 2 Disulfides 2 Biopsy 2 tremelimumab 1 tislelizumab 1 sofosbuvir-velpatasvir drug combination 1 sargramostim 1 sapanisertib 1 rocakinogene sifuplasmid 1 relatlimab 1 recombinant interferon alpha 2b-like protein 1 fludarabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡